Our office space facilities are 80% utilized, while our lab space and farm facilities are 50% utilized. We have no material tangible fixed assets apart from the leased properties described above.

filing / Mar 26, 2026 / receipt

severance, retirement, car, phone or similar benefits or expenses, but does not include business travel, relocation, professional and

filing / Mar 26, 2026 / receipt

pension fund benefits for all employees, insurance for work-related accidents, recuperation pay and travel expenses. None of our employees is represented by a labor union or covered under a collective bargaining agreement.

filing / Mar 26, 2026 / receipt

Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2025, to provide

filing / Mar 26, 2026 / receipt

of 1,870 square meters (approximately 20,129 square feet) of leased office space accommodating our corporate offices and our molecular,

filing / Mar 26, 2026 / receipt

as Evogene's President and Chief Executive Officer since December 2004 after having joined the company in January 2002 as Chief Financial

filing / Mar 26, 2026 / receipt

Mr. Ofer Haviv | 59 | President and Chief Executive Officer and Director

filing / Mar 26, 2026 / receipt

Mr. Yaron Eldad | 60 | Chief Financial Officer

filing / Mar 26, 2026 / receipt

Dr. Gabi Tarcic | 46 | Vice President Product

filing / Mar 26, 2026 / receipt

Dr. Ilia Zhidkov | 49 | Vice President Computational Platform

filing / Mar 26, 2026 / receipt